AU2002251310A1 - Viral vector system to transduce or infect a target adipose tissue site - Google Patents

Viral vector system to transduce or infect a target adipose tissue site

Info

Publication number
AU2002251310A1
AU2002251310A1 AU2002251310A AU2002251310A AU2002251310A1 AU 2002251310 A1 AU2002251310 A1 AU 2002251310A1 AU 2002251310 A AU2002251310 A AU 2002251310A AU 2002251310 A AU2002251310 A AU 2002251310A AU 2002251310 A1 AU2002251310 A1 AU 2002251310A1
Authority
AU
Australia
Prior art keywords
transduce
infect
viral vector
adipose tissue
tissue site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002251310A
Inventor
Fiona Margaret Ellard
Susan A. Kingsman
Kyriacos Mitrophanous
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Biomedica UK Ltd
Original Assignee
Oxford Biomedica UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Biomedica UK Ltd filed Critical Oxford Biomedica UK Ltd
Publication of AU2002251310A1 publication Critical patent/AU2002251310A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15045—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
AU2002251310A 2001-04-20 2002-04-19 Viral vector system to transduce or infect a target adipose tissue site Abandoned AU2002251310A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0109781A GB0109781D0 (en) 2001-04-20 2001-04-20 Vector system
GB0109781.5 2001-04-20
PCT/GB2002/001830 WO2002086132A2 (en) 2001-04-20 2002-04-19 Viral vector system to transduce or infect a target adipose tissue site

Publications (1)

Publication Number Publication Date
AU2002251310A1 true AU2002251310A1 (en) 2002-11-05

Family

ID=9913181

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002251310A Abandoned AU2002251310A1 (en) 2001-04-20 2002-04-19 Viral vector system to transduce or infect a target adipose tissue site

Country Status (4)

Country Link
EP (1) EP1385969A2 (en)
AU (1) AU2002251310A1 (en)
GB (1) GB0109781D0 (en)
WO (1) WO2002086132A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869037A (en) * 1996-06-26 1999-02-09 Cornell Research Foundation, Inc. Adenoviral-mediated gene transfer to adipocytes
JP2001501471A (en) * 1996-09-24 2001-02-06 メルク エンド カンパニー インコーポレーテッド Gene therapy for inhibiting angiogenesis
GB2327224A (en) * 1997-07-09 1999-01-20 Mayo Foundation Gene transfer to adipocytes

Also Published As

Publication number Publication date
EP1385969A2 (en) 2004-02-04
WO2002086132A3 (en) 2003-05-08
GB0109781D0 (en) 2001-06-13
WO2002086132A2 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
AU2001244675A1 (en) Aids virus vaccine with the use of sendai virus vector
HUP0400685A3 (en) Modified vaccinia ankara virus variant
AU2002352867A1 (en) Joint angle indication system
AU1224501A (en) Surgical drape
GB0324402D0 (en) Target system
AU5367101A (en) Surgical targeting system
AU2003238456A1 (en) Viral vector
AU2001268373A1 (en) Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus
AU3328900A (en) Influenza virus hemagglutinin-binding peptides
AU2003248656A1 (en) Surgical draping system
AU2001277960A1 (en) 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by vla-4
AU2104201A (en) Irrigating forceps
EP1505999A4 (en) Low molecular weight protein tyrosine phosphatase (lmw-ptp) as a diagnostic and therapeutic target
AU2002251310A1 (en) Viral vector system to transduce or infect a target adipose tissue site
AUPQ233799A0 (en) Recombinant sub-unit vaccine
AU2709401A (en) Detection of biological target
AU2002320230A1 (en) Distal anastomosis system
AUPR160400A0 (en) Plant virus promoter
AU2002243257A1 (en) Oncolytic virus
MA25765A1 (en) USE OF STRAINS OF PARAPOX VIRUS OVIS AGAINST ORGAN FIBROSIS.
AU2001285827A1 (en) Use of strains of the parapox ovis virus against organ fibrosis
AU2001285827A2 (en) Use of strains of the parapox ovis virus against organ fibrosis
AU2003251356A1 (en) Viral marker
AU2960000A (en) Detection of human immunodeficiency virus
AU4957800A (en) Vaccine against isa virus

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase